In addition, CD44+/CD24−/low CSC subset in breast cancer is resistant to radiation via activation of ATM signaling but does not depend on alteration of nonhomologous end joining (NHEJ) DNA repair activity [91]. The gene discussed is CD44; the disease is breast carcinoma.